Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.31 |
| ▸ | STAT1 | P42224 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7163065 | 0.99 | STAT3 (0.32) | STAT3STAT1 | |
| SCHEMBL7156706 | 0.84 | HTR1B (0.34) | STAT3STAT1 | |
| SCHEMBL7157689 | 0.81 | STAT3 (0.39) | STAT3STAT1 | |
| SCHEMBL7163054 | 0.80 | STAT3 (0.40) | STAT3STAT1 | |
| SCHEMBL27633442 | 0.78 | MAPT (0.36) | STAT3STAT1 | |
| SCHEMBL7156701 | 0.77 | STAT3 (0.31) | STAT3STAT1 | |
| SCHEMBL27894257 | 0.74 | PDE4A (0.41) | STAT3STAT1 | |
| SCHEMBL30497518 | 0.73 | STAT3 (0.37) | STAT3STAT1 | |
| SCHEMBL480532 | 0.73 | STAT3 (0.37) | STAT3STAT1 | |
| SCHEMBL28470756 | 0.72 | STAT3 (0.36) | STAT3STAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6548045-B2 | Anticancer agents | PHOTOCHEMICAL CO., LTD. (JP) | 2003-04-15 | — | — | US | disclosed |
| US-20020177704-A1 | NITROIMIDAZOLE SUBSTITUTED PORPHYRIN COMPLEX | PHOTOCHEMICAL CO., LTD. (JP) | 2002-11-28 | — | — | US | disclosed |
| EP-1148057-A1 | NITROIMIDAZOLE-SUPPORTING PORPHYRIN COMPLEX | Photochemical Co., Ltd. (JP) | 2001-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020177704-A1 | NITROIMIDAZOLE SUBSTITUTED PORPHYRIN COMPLEX | MT-CO3, HCCS, MT-CO1 | STAT3 943/4885STAT1 1060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.